Results 41 to 50 of about 187,751 (309)

Current Status and Future Perspectives of Robotic Surgery for Esophagogastric Cancer in Asia

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Robotic‐assisted surgery (RAS) has moved from an experimental adjunct to an increasingly established component of gastrointestinal (GI) oncological practice in parts of Asia, a region that carries a disproportionately high burden of gastric and esophageal cancer. Asian surgeons have been among the earliest and most prolific contributors to the
Jia Jun Ang, Jimmy Bok Yan So
wiley   +1 more source

Pharmaceutical pricing and reimbursement information (PPRI): evolution and impact of a policy network over two decades

open access: yesJournal of Pharmaceutical Policy and Practice
Background In 2005, the Pharmaceutical Pricing and Reimbursement Information (PPRI) network of public authorities was established to offer a platform for information exchange among authorities responsible for pharmaceutical pricing and reimbursement. The
Sabine Vogler   +3 more
doaj   +1 more source

Affordability of oncology drugs: accuracy of budget impact estimations

open access: yesJournal of Market Access & Health Policy, 2020
Background: In many countries, Budget Impact (BI) informs reimbursement decisions. Evidence has shown that decision-makers have restricted access based on high BI estimates but studies show that BI estimates are often inaccurate. Objective: To assess the
Joost W. Geenen   +4 more
doaj   +1 more source

Examining the association between oncology drug clinical benefit and the time to public reimbursement

open access: yesCancer Medicine, 2022
Background We examined if oncology drug indications with high clinical benefit, as measured by the American Society of Clinical Oncology Value Framework (ASCO‐VF) and European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO‐MCBS ...
Sasha Thomson   +7 more
doaj   +1 more source

Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland? [PDF]

open access: yes, 2011
This paper aims to fill in the gap in research on the effect of pharmaceutical lobbying on drug reimbursement policy, particularly in Poland, a post-communist country.
Piotr Ozierański   +8 more
core   +1 more source

Comparison of Nationwide Volumes for Five Major Gastrointestinal Surgical Procedures in Japan: Implications From Publicly Available NCD and NDB Open Data

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Aim In Japan, the National Clinical Database (NCD), a clinician‐reported registry, and the National Database of Health Insurance Claims and Specific Health Checkups of Japan Open Data (NDB Open Data), an administrative claims database, are both widely used as nationwide surgical databases, but their consistency in capturing national surgical ...
Atomu Kiriyama   +3 more
wiley   +1 more source

Innovative Payment Mechanisms for High-Cost Medical Devices in Latin America: Experience in Designing Outcome Protection Programs in the Region

open access: yesJournal of Market Access & Health Policy
Introduction and Objectives: Risk-sharing agreements (RSAs) have emerged as a key strategy for financing high-cost medical technologies while ensuring financial sustainability.
Daniela Paredes-Fernández   +1 more
doaj   +1 more source

Premium subsidy designs and crowding out of insurance demand

open access: yesAmerican Journal of Agricultural Economics, EarlyView.
Abstract Crop insurance is an important instrument to protect farmers against extreme weather events. Many countries provide subsidies for crop insurance products to make insurance more affordable for farmers. The Federal Crop Insurance Program in the United States and major European crop insurance programs such as in Spain, Italy, and France focus on ...
Tim Philippi
wiley   +1 more source

Descriptive Epidemiology From the Myhre Syndrome Foundation Registry: The Value of Self‐Reported Data

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Myhre syndrome is an ultrarare genetic disease characterized by short stature, distinct craniofacial features, cardiovascular and respiratory fibrosis and stenosis, neurodevelopmental delays, autism, intellectual disability, and hearing loss. The natural history of Myhre syndrome is still not fully understood due to a small patient population ...
Mary K. Young   +6 more
wiley   +1 more source

Participatory Policy Development: Reflections on Designing the Strong Roots for Our Futures Program in Victoria

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT In this paper, we trace the journey to create the Strong Roots for our Futures Program, a government program to resource and support Traditional Owners to undertake a range of activities in areas where no state recognition existed. We provide a background to state recognition in Victoria before considering the program design, leading to an ...
Nell Reidy   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy